[ad_1]
(MedPage Today) — Improved targeting of the molecular drivers of psoriasis has paved the way for new oral therapies that offer the potential for major responses in a majority of patients.
Identification of better targets — combined with better…
[ad_2]
Source link : https://www.medpagetoday.com/spotlight/aad-psoriasis/114966
Author :
Publish date : 2025-04-04 14:37:00
Copyright for syndicated content belongs to the linked Source.